Institutional Ownership Eliem Therapeutics, Inc. (ELYM)
This table provides information about the institutional ownership of Eliem Therapeutics, Inc. (ELYM). We have compiled data on the 76 institutions that hold shares in the stock, with a total of 51 Million shares, which have been reported (via 13F filing form) to have a value of $210 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Ra Capital Management, L.P.
Boston, MA |
Feb 14, 2025 Q4 2024 |
31,419,267
shares
|
$129 Million
2.09% of portfolio
|
Q2 2024
New holding
|
|
|
Janus Henderson Group PLC
London, X0 |
Feb 14, 2025 Q4 2024 |
3,184,200
shares
|
$13.1 Million
0.01% of portfolio
|
Q4 2024
Reduced 11.71%
|
|
|
Samsara Bio Capital, LLC
Palo Alto, CA |
Feb 14, 2025 Q4 2024 |
2,609,114
shares
|
$10.7 Million
3.29% of portfolio
|
Q3 2024
Reduced 20.0%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
1,506,257
shares
|
$6.19 Million
0.0% of portfolio
|
Q4 2024
Reduced 1.22%
|
|
|
Deep Track Capital, LP
Greenwich, CT |
Feb 14, 2025 Q4 2024 |
1,040,115
shares
|
$4.27 Million
0.19% of portfolio
|
Q4 2024
Reduced 52.05%
|
|
|
Bank Of America Corp
Charlotte, NC |
Feb 14, 2025 Q4 2024 |
1,033,692
shares
|
$4.25 Million
0.0% of portfolio
|
Q4 2024
Added 5851.36%
|
|
|
Ally Bridge Group (Ny) LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
760,225
shares
|
$3.12 Million
3.55% of portfolio
|
Q4 2024
Reduced 38.16%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
660,831
shares
|
$2.72 Million
0.0% of portfolio
|
Q4 2024
Added 1.46%
|
|
|
Cantor Fitzgerald, L. P.
New York, NY |
Feb 14, 2025 Q4 2024 |
650,500
shares
|
$2.67 Million
0.11% of portfolio
|
Q4 2024
New holding
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Feb 14, 2025 Q4 2024 |
628,650
shares
|
$2.58 Million
0.0% of portfolio
|
Q4 2024
Reduced 6.53%
|
|
|
Kynam Capital Management, LP
Princeton, NJ |
Feb 14, 2025 Q4 2024 |
547,000
shares
|
$2.25 Million
0.14% of portfolio
|
Q4 2024
New holding
|
|
|
Affinity Asset Advisors, LLC
New York, NY |
Feb 13, 2025 Q4 2024 |
500,000
shares
|
$2.06 Million
0.37% of portfolio
|
Q4 2024
Reduced 66.67%
|
|
|
Schonfeld Strategic Advisors LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
465,100
shares
|
$1.91 Million
0.01% of portfolio
|
Q4 2024
New holding
|
|
|
Nan Fung Group Holdings LTD
Central, K3 |
Feb 13, 2025 Q4 2024 |
463,654
shares
|
$1.91 Million
1.89% of portfolio
|
Q3 2024
New holding
|
|
|
Ubs Group Ag
|
Feb 14, 2025 Q4 2024 |
415,355
shares
|
$1.71 Million
0.0% of portfolio
|
Q4 2024
Added 2456.5%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
381,723
shares
|
$1.57 Million
0.0% of portfolio
|
Q2 2024
Added 1154.02%
|
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
378,536
shares
|
$1.56 Million
0.0% of portfolio
|
Q4 2024
Added 20.16%
|
|
|
Diadema Partners LP
Morristown, NJ |
Feb 14, 2025 Q4 2024 |
374,423
shares
|
$1.54 Million
0.29% of portfolio
|
Q4 2024
New holding
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Feb 13, 2025 Q4 2024 |
372,300
shares
|
$1.53 Million
0.0% of portfolio
|
Q4 2024
Added 442.71%
|
|
|
Northern Trust Corp
Chicago, IL |
Feb 14, 2025 Q4 2024 |
313,838
shares
|
$1.29 Million
0.0% of portfolio
|
Q4 2024
Added 7.25%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Feb 12, 2025 Q4 2024 |
291,796
shares
|
$1.2 Million
0.0% of portfolio
|
Q4 2024
Added 2183.94%
|
|
|
Parkman Healthcare Partners LLC
Stamford, CT |
Feb 14, 2025 Q4 2024 |
290,491
shares
|
$1.19 Million
0.17% of portfolio
|
Q4 2024
Added 4.2%
|
|
|
Sphera Funds Management Ltd.
Tel Aviv, L3 |
Feb 14, 2025 Q4 2024 |
251,935
shares
|
$1.04 Million
0.21% of portfolio
|
Q4 2024
Added 38.45%
|
|
|
Allostery Investments LP
Stamford, CT |
Feb 14, 2025 Q4 2024 |
244,988
shares
|
$1.01 Million
0.46% of portfolio
|
Q4 2024
New holding
|
|
|
Two Sigma Investments, LP
New York, NY |
Feb 14, 2025 Q4 2024 |
237,710
shares
|
$976,988
0.0% of portfolio
|
Q4 2024
Added 910.93%
|